The comorbidities of migraine

The Migraine in America Symptoms and Treatment (MAST) study was designed to evaluate patterns of migraine consultation, diagnosis, treatment and comorbid health burden among a representative non-clinical sample of people with migraine, who had an average of at least one headache day per month.^{[Buse et al., 2020]} The study was a web-based survey of 15,133 people with migraine, and 77,453 control individuals.^{[Buse et al., 2020]} Participants were asked about comorbidities and other conditions with the question: “Do you have, or have you ever had, any of the following health conditions?”^{[Buse et al., 2020]} Participants were then presented with a list of diseases and conditions.^{[Buse et al., 2020]} The results of the MAST study showed that a wide range of conditions were comorbid with migraine, occurring from slightly more than one times the control group to almost four times more.^{[Buse et al., 2020]}

Reference:
Buse DC, Reed ML, Fanning KM, et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the Migraine in America Symptoms and Treatment (MAST) study. J Headache Pain 2020; 21 (1): 23.